The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Syngenta Receives Approval for Agrisure Viptera? in Argentina

Thursday, May 26, 2011

Syngenta Receives Approval for Agrisure Viptera? in Argentina01:00 EDT Thursday, May 26, 2011- Full cultivation approval for MIR162 on corn in Argentina - Trait offers unprecedented level of pest control - Strengthens Syngenta corn offer for growers in ArgentinaBASEL, Switzerland, May 26, 2011 /PRNewswire/ -- Syngenta announced today that it has received cultivation approval for its MIR162 trait, branded Agrisure Viptera?, from the Ministry of Agriculture in Argentina. MIR162 offers excellent control of key insects such as fall armyworm, sugarcane borer and corn earworm as well as other damaging lepidopteran pests. "We are pleased to receive this approval for Agrisure Viptera?, which demonstrates Syngenta's innovation and outperformance in corn," said John Atkin, Syngenta Chief Operating Officer. "Following the successful launches in the USA and Brazil, this approval is further evidence of our ability to leverage technology across regions." The trait will broaden Syngenta's corn offer in Argentina and will be available to Argentine growers for the 2011/2012 season. MIR162 has already been approved for cultivation in the USA, Canada and Brazil.Syngenta is one of the world's leading companies with more than 26,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life.  Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life.  For more information about us please go to www.syngenta.com.Cautionary Statement Regarding Forward-Looking StatementsThis document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.Syngenta International AGMedia OfficeCH-4002 BaselSwitzerlandTel:          +41 61 323 23 23Fax:         +41 61 323 24 24www.syngenta.com Media contacts:Michael Edmond IsaacSwitzerland      +41 61 323 2323  Roman BartomeoArgentina         +54 11 4837 6558Analyst/Investor contacts:Jennifer GoughSwitzerland   +41 61 323 5059USA              +1 202 737 6521Claire HinshelwoodSwitzerland   +41 61 323 7812USA              +1 202 737 6520SOURCE Syngenta